Compare · head to head
Chongkundang Holdings vs Whanin Pharm
Whanin Pharm ranks higher overall — 360 rank 99 vs 56.
Whanin Pharm leads on Value (62 vs 55), Growth (72 vs 58), Safety (69 vs 27) and Sentiment (61 vs 52). Chongkundang Holdings leads on Quality (64 vs 57).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | South Korea | South Korea |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Small |
| ISIN | KR7001630003 | KR7016580003 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 56 | 99 |
| Value | 55 | 62 |
| Quality | 64 | 57 |
| Growth | 58 | 72 |
| Safety | 27 | 69 |
| Sentiment | 52 | 61 |
| Quality details | ||
| Profitability | 73 | 70 |
| Cash Truth | 55 | 45 |
Chongkundang Holdings vs Kyongbo PharmaceuticalChongkundang Holdings vs Bora PharmaceuticalsChongkundang Holdings vs Reyon PharmaceuticalChongkundang Holdings vs BoryungAdd a third stock →
Full analyses: Chongkundang Holdings · Whanin Pharm
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100